English   español  

Browsing by Author Pandiella, Atanasio

Showing results 1 to 20 of 59  next >
RightsIssue DateTitleAuthor(s)Type
closedAccess2011A modular approach to trim cellular targets in anticancer drug discoveryRíos-Luci, Carla; Díaz-Rodríguez, Elena; Pandiella, AtanasioArtículo
closedAccess2005Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptinYuste, Laura; Montero, Juan Carlos; Esparís-Ogando, Azucena; Pandiella, AtanasioArtículo
closedAccess2008Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivoMitsiades, C. S.; Ocio, Enrique M.; Pandiella, Atanasio; Maiso, Patricia; Gajate, Consuelo; Garayoa, Mercedes; Vilanova, David; Montero, Juan Carlos; Mollinedo, Faustino; San Miguel, Jesús F.Artículo
closedAccess1996Autocrine regulation of membrane transforming growth factor-α cleavagePandiella, AtanasioArtículo
closedAccessNov-2010Autophagy inhibition sensitizes multiple myeloma cells to 17-dimethylaminoethylamino-17-demethoxygeldanamycin-induced apoptosisPalacios, Carmen; Martín-Pérez, Rosa; López-Pérez, Ana Isabel; Pandiella, Atanasio; López-Rivas, AbelardoArtículo
closedAccess1999Cleavage of the TrkA neurotrophin receptor by multiple metalloproteases generates signalling-competent truncated formsDíaz-Rodríguez, Elena; Cabrera, Noemí; Esparís-Ogando, Azucena; Montero, Juan Carlos; Pandiella, AtanasioArtículo
openAccess2012Dasatinib as a bone-modifying agent: Anabolic and anti-resorptive effectsGarcia-Gomez, Antonio; Ocio, Enrique M.; Crusoe, Edvan; Santamaría, Carlos; Sánchez-Guijo, Fermín M.; Hernández, M. Teresa; Pandiella, Atanasio; San Miguel, Jesús F.; Garayoa, MercedesArtículo
openAccess2011Deficient spindle assembly checkpoint in multiple myelomaDíaz-Rodríguez, Elena; Álvarez-Fernández, Stela; Chen, Xi; Paiva, Bruno; López-Pérez, Ricardo; García, Juan L.; San Miguel, Jesús F.; Pandiella, AtanasioArtículo
closedAccess2012Differential action of small molecule HER kinase inhibitors on receptor heterodimerization: Therapeutic implicationsSánchez-Martín, M.; Pandiella, AtanasioArtículo
closedAccess2000Differential shedding of transmembrane neuregulin isoforms by the tumor necrosis factor-α-converting enzymeMontero, Juan Carlos; Yuste, Laura; Díaz-Rodríguez, Elena; Esparís-Ogando, Azucena; Pandiella, AtanasioArtículo
openAccess2010Do We Have to Change the Way Targeted Drugs Are Developed?Ocaña, Alberto; Pandiella, AtanasioArtículo
openAccess22-Sep-2010Effect of multikinase inhibitors on caspase-independent cell death and DNA damage in HER2-overexpressing breast cancer cellsSeoane, Samuel; Montero, Juan Carlos; Ocaña, Alberto; Pandiella, AtanasioArtículo
closedAccess2004Endoglin expression regulates basal and TGF-β1-induced extracellular matrix synthesis in cultured L6E9 myoblastsObreo, Juana; Diez-Marques, Luisa M.; Lamas Peláez, Santiago; Düwell, Annette; Eleno, Nélida; Bernabéu Quirante, Carmelo; Pandiella, Atanasio; Lopez-Novoa, José Miguel; Rodriguez-Barbero, AliciaArtículo
closedAccess2006Endoglin modulation of TGF-beta1-induced collagen synthesis is dependent on ERK1/2 MAPK activationRodriguez-Barbero, Alicia; Obreo, Juana; Alvarez-Muñoz, Patricia; Pandiella, Atanasio; Bernabéu Quirante, Carmelo; Lopez-Novoa, José MiguelArtículo
closedAccess2010Enhancement of antiproliferative activity by molecular simplification of catalpolGarcía, Celina; Ríos-Luci, Carla; Montero, Juan Carlos; Pandiella, AtanasioArtículo
openAccess1-Jul-2009ERK2, but Not ERK1, Mediates Acquired and “De novo” Resistance to Imatinib Mesylate: Implication for CML TherapyAceves-Luquero, Clara I.; Esparís-Ogando, Azucena; Pandiella, AtanasioArtículo
closedAccess2007Erk5 is activated and acts as a survival factor in mitosisGírio, Ana; Montero, Juan Carlos; Pandiella, AtanasioArtículo
closedAccess2007Erk5 nuclear location is independent on dual phosphorylation, and favours resistance to TRAIL-induced apoptosisBorges, Joana; Pandiella, Atanasio; Esparís-Ogando, AzucenaArtículo
closedAccessJan-2002Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2Esparís-Ogando, Azucena; Díaz-Rodríguez, Elena; Montero, Juan Carlos; Yuste, Laura; Crespo, Piero; Pandiella, AtanasioArtículo
openAccess15-May-2009Expression of Erk5 in early stage breast cancer and association with disease free survival identifies this kinase as a potential therapeutic targetMontero, Juan Carlos; Ocaña, Alberto; Abad, María del Mar; Ortiz-Ruiz, María Jesús; Pandiella, Atanasio; Esparís-Ogando, AzucenaArtículo